Ohio State will lead a $12M NIH-funded trial comparing BiPAP and HFNO to improve emergency respiratory care for patients with acute respiratory failure.

Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...

In a classic “two steps forward, one step back” situation, just as Philips is aiming to wrap up the repair-and-replace program for the 5.5 million respiratory devices it began recalling two years ago, ...